LOGIN
COA-ACO2018: Comparison of VTE prophylaxis of aspirin vs. extended rivaroxaban after TKA/THA
January 2019
COA-ACO2018: Comparison of VTE prophylaxis of aspirin vs. extended rivaroxaban after TKA/THA
Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A
Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban To Aspirin Following Total Hip And Knee Arthroplasty (EPCAT II)
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
3424 patients scheduled for or who had undergone either total knee or hip arthroplasty with a 5-day course of rivaroxaban 10mg postoperatively were randomized to extended thromboprophylaxis with either aspirin 81mg daily or continued rivaroxaban 10mg daily. Patients were assessed for the incidence of venous thromboembolism and bleeding events over the first 90 days after surgery, Noninferiority an...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.